Gavin Robertson

Gavin Robertson is a Professor at the Pennsylvania State University, holding appointments in the Departments of Molecular and Precision Medicine, Dermatology, Pathology and Laboratory Medicine, and Surgery. He directs the Melanoma and Skin Cancer Center, Penn State Melanoma Therapeutics Program, and the Foreman Foundation Melanoma Research Laboratory.

• His research focuses on malignant melanoma, emphasizing Akt3 signaling, aldehyde dehydrogenase inhibition, and telomerase regulation as therapeutic targets.
• He employs genetic studies, medicinal chemistry, and nanotechnology for drug discovery and delivery, including clinical trials for agents like CADI-5 and ISC-4.

Recent publications highlight his work on telomerase manipulation in acral melanoma, p53 pathway immunity, and multi-isoform ALDH inhibitors. His research aligns with UN Sustainable Development Goals related to health and well-being.

• Grants include multiple National Cancer Institute projects (2006–2025) targeting melanoma chemoprevention and synergistic therapies.